News

Diet, Exercise Help Delay Onset of Diabetes

Author and Disclosure Information

Major finding: At 23-year follow-up, the intervention group had a 41% lower risk of cardiovascular disease mortality, a 29% lower risk of all-cause mortality, and a 45% lower incidence of diabetes, all significant differences. The mortality effect was seen mainly in women.

Data source: The Da Qing Diabetes Prevention Study of 577 adults with impaired glucose tolerance randomized to a control group or a 6-year intervention program consisting of diet, exercise, or both.

Disclosures: The Centers for Disease Control and Prevention, the World Health Organization, the China-Japan Friendship Hospital, and the Da Qing First Hospital funded the study. The investigators reported that they had no competing interests.


 

FROM THE LANCET DIABETES & ENDOCRINOLOGY

A 6-year program of diet, exercise, or both helped delay the onset of diabetes in adults, and had significant mortality benefits for women 23 years later, researchers reported online in the Lancet Diabetes & Endocrinology.

The Da Qing Diabetes Prevention Study "is the first to show that lifestyle intervention in people with impaired glucose tolerance can both reduce the incidence of diabetes and decrease mortality," said Dr. Guangwei Li at the China-Japan Friendship Hospital in Beijing and his associates.

©Pavel Losevsky/iStockphoto.com

Altering dietary and exercise habits may be the best option for patients who wish to delay the onset of diabetes.

They added that the results "provide yet further justification to implement lifestyle interventions for people with impaired glucose tolerance.".

The investigators randomized 577 Chinese adults with impaired glucose tolerance to a control group or to a 6-year intervention program consisting of diet, exercise, or both. The exercise program focused on increasing leisure physical activity, while the diet program promoted weight loss when indicated and reduction of carbohydrate and alcohol intake.

At 23-year follow-up, the intervention group had significantly lower rates of cardiovascular mortality, at 11.9% vs. 19.6%, for a relative risk reduction of 41%; all-cause mortality, at 28.1% vs. 38.4%, for a RRR of 29%; and diabetes, at 72.6% vs. 89.9%, yielding a RRR of 45% (Lancet Diabetes Endocrinol. 2014 [doi: 10.1016/S2213-8587(14)70057-9]).

But the mortality benefit was significant only in women, in whom the risk reductions were 54% and 72% for cardiovascular and all-cause death, respectively, compared with just 3% and 9% in men. The researchers said they could not determine why the mortality benefit was seen primarily in women. Controlling for a higher smoking rate in men did not account for the difference, they said.

The U.S. Centers for Disease Control and Prevention, the World Health Organization, the China-Japan Friendship Hospital, and the Da Qing First Hospital funded the study. The investigators reported that they had no competing interests.

Recommended Reading

Diabetes Morbidity Varies with Patient Age, Disease Duration
Clinician Reviews
High Burden of Insulin-related Hypoglycemia
Clinician Reviews
Curb Vaccine-preventable Diseases in Patients with Diabetes
Clinician Reviews
Mindfulness Training Shifts Patients with Diabetes Off Autopilot
Clinician Reviews
Rising to the Challenge of Glucose Control Before and After Surgery
Clinician Reviews
Diabetic Amyotrophy: A Rare but Striking Neuropathy
Clinician Reviews
Is Bariatric Surgery the Right Treatment Model for Obesity?
Clinician Reviews
FDA Panel Backs Approval of Inhaled Insulin for Type 1 and 2 Diabetes
Clinician Reviews
Weekly Exenatide Shows Long-term Efficacy in Type 2 Diabetes
Clinician Reviews
Diabetes Prevalence Increases, But so Does Diabetes Control
Clinician Reviews